Hua‐Zhen Xu

1.1k total citations
38 papers, 809 citations indexed

About

Hua‐Zhen Xu is a scholar working on Biomedical Engineering, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Hua‐Zhen Xu has authored 38 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Biomedical Engineering, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Immunology. Recurrent topics in Hua‐Zhen Xu's work include Nanoplatforms for cancer theranostics (15 papers), Immune cells in cancer (10 papers) and Photodynamic Therapy Research Studies (7 papers). Hua‐Zhen Xu is often cited by papers focused on Nanoplatforms for cancer theranostics (15 papers), Immune cells in cancer (10 papers) and Photodynamic Therapy Research Studies (7 papers). Hua‐Zhen Xu collaborates with scholars based in China, Japan and United States. Hua‐Zhen Xu's co-authors include Xiao Chen, Tong‐Fei Li, Li Zhao, Xing‐Chun Peng, Ning Han, Tingting Yu, Liu‐Gen Li, Xiang Xu, Qi‐Rui Li and Yong‐Hong Xu and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Hua‐Zhen Xu

36 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hua‐Zhen Xu China 17 348 302 243 171 150 38 809
Jungshan Chang Taiwan 19 200 0.6× 386 1.3× 91 0.4× 156 0.9× 138 0.9× 50 909
Chaoming Mei China 16 360 1.0× 270 0.9× 94 0.4× 63 0.4× 222 1.5× 25 744
Rita Mendes Portugal 11 414 1.2× 590 2.0× 182 0.7× 268 1.6× 156 1.0× 16 1.4k
Lingpu Zhang China 13 373 1.1× 273 0.9× 145 0.6× 161 0.9× 177 1.2× 24 756
Qianhui Xu China 12 256 0.7× 308 1.0× 172 0.7× 75 0.4× 195 1.3× 21 744
Mingyue Cai China 18 187 0.5× 206 0.7× 151 0.6× 150 0.9× 63 0.4× 53 1.1k
Aaron H. Colby United States 21 331 1.0× 379 1.3× 144 0.6× 92 0.5× 66 0.4× 33 956
Yawen Guo China 18 142 0.4× 326 1.1× 77 0.3× 122 0.7× 99 0.7× 51 1.0k
Liteng Lin China 18 268 0.8× 368 1.2× 111 0.5× 266 1.6× 67 0.4× 39 1.1k

Countries citing papers authored by Hua‐Zhen Xu

Since Specialization
Citations

This map shows the geographic impact of Hua‐Zhen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua‐Zhen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua‐Zhen Xu more than expected).

Fields of papers citing papers by Hua‐Zhen Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua‐Zhen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua‐Zhen Xu. The network helps show where Hua‐Zhen Xu may publish in the future.

Co-authorship network of co-authors of Hua‐Zhen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Hua‐Zhen Xu. A scholar is included among the top collaborators of Hua‐Zhen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua‐Zhen Xu. Hua‐Zhen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ruibin, Yanan Wu, Yufan Zhang, et al.. (2025). TaPP2C‐a6 interacts with TaDOG1Ls and regulates seed dormancy and germination in wheat. Plant Biotechnology Journal. 23(8). 3313–3329. 1 indexed citations
2.
Sun, Zicheng, Hua‐Zhen Xu, Guanming Lu, et al.. (2025). AKT1 Phosphorylates FDX1 to Promote Cuproptosis Resistance in Triple‐Negative Breast Cancer. Advanced Science. 12(17). e2408106–e2408106. 14 indexed citations
3.
Bai, Ren-Yuan, Jianan Liu, Yuqing Lu, et al.. (2025). Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. Nature Communications. 16(1). 8594–8594.
4.
Xu, Hua‐Zhen, et al.. (2025). Neutrophil Dynamics in Response to Cancer Therapies. Cancers. 17(15). 2593–2593. 1 indexed citations
5.
Xu, Hua‐Zhen, et al.. (2025). Chelation and nanoparticle delivery of monomeric dopamine to increase plant salt stress resistance. Nature Communications. 16(1). 4157–4157. 8 indexed citations
6.
Xu, Hua‐Zhen, Xiuli Lu, Mei Li, et al.. (2024). Jiangu formula: A novel osteoclast-osteoblast coupling agent for effective osteoporosis treatment. Phytomedicine. 128. 155501–155501. 5 indexed citations
7.
Zheng, Qingyuan, Rui Yang, Hua‐Zhen Xu, et al.. (2023). A Weakly Supervised Deep Learning Model and Human–Machine Fusion for Accurate Grading of Renal Cell Carcinoma from Histopathology Slides. Cancers. 15(12). 3198–3198. 14 indexed citations
8.
Xu, Hua‐Zhen, Tongfei Li, Ke Li, et al.. (2023). Sonodynamic therapy of glioblastoma mediated by platelets with ultrasound-triggered drug release. Drug Delivery. 30(1). 2219429–2219429. 9 indexed citations
9.
Han, Ning, Ziyi Yang, Hua‐Zhen Xu, et al.. (2023). Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy. Phytomedicine. 112. 154682–154682. 51 indexed citations
10.
Wang, Chao, Yong‐Hong Xu, Hua‐Zhen Xu, et al.. (2023). PD-L1 blockade TAM-dependently potentiates mild photothermal therapy against triple-negative breast cancer. Journal of Nanobiotechnology. 21(1). 476–476. 6 indexed citations
11.
Zheng, Qingyuan, Jingsong Wang, Kai Wang, et al.. (2023). Predicting Lymph Node Metastasis Status from Primary Muscle-Invasive Bladder Cancer Histology Slides Using Deep Learning: A Retrospective Multicenter Study. Cancers. 15(11). 3000–3000. 6 indexed citations
12.
Yu, Tingting, Ning Han, Liu‐Gen Li, et al.. (2022). Chlorin e6-Induced Photodynamic Effect Polarizes the Macrophage Into an M1 Phenotype Through Oxidative DNA Damage and Activation of STING. Frontiers in Pharmacology. 13. 837784–837784. 15 indexed citations
13.
Han, Ning, Liu‐Gen Li, Xing‐Chun Peng, et al.. (2022). Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancer through inhibiting GPX4 and enhancing ROS. European Journal of Pharmacology. 919. 174797–174797. 49 indexed citations
14.
Zhang, Haifei, et al.. (2022). Unselfish Cooperative Game-Based Communication Optimization of ECG Monitoring Network. 13–17. 1 indexed citations
15.
Xu, Hua‐Zhen, Tong‐Fei Li, Yan Ma, et al.. (2022). Targeted photodynamic therapy of glioblastoma mediated by platelets with photo-controlled release property. Biomaterials. 290. 121833–121833. 49 indexed citations
16.
Shen, Xinkun, Suji Han, Nan Liu, et al.. (2021). LINC00887 aggravates the malignant progression of glioma via upregulating CCND1. SHILAP Revista de lepidopterología. 6 indexed citations
17.
Yu, Tingting, Ning Han, Xing‐Chun Peng, et al.. (2021). Macrophages mediated delivery of chlorin e6 and treatment of lung cancer by photodynamic reprogramming. International Immunopharmacology. 100. 108164–108164. 17 indexed citations
18.
Yuan, Shen-Jun, Chao Wang, Hua‐Zhen Xu, et al.. (2021). Conjugation with nanodiamonds via hydrazone bond fundamentally alters intracellular distribution and activity of doxorubicin. International Journal of Pharmaceutics. 606. 120872–120872. 16 indexed citations
19.
Chen, Zhuo, Shen-Jun Yuan, Ke Li, et al.. (2020). Doxorubicin-polyglycerol-nanodiamond conjugates disrupt STAT3/IL-6-mediated reciprocal activation loop between glioblastoma cells and astrocytes. Journal of Controlled Release. 320. 469–483. 30 indexed citations
20.
Yuan, Shen-Jun, Yong‐Hong Xu, Chao Wang, et al.. (2019). Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer. Journal of Nanobiotechnology. 17(1). 110–110. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jungshan Chang Breakdown of academic impact, for papers by Chaoming Mei Breakdown of academic impact, for papers by Rita Mendes Breakdown of academic impact, for papers by Lingpu Zhang Breakdown of academic impact, for papers by Qianhui Xu Breakdown of academic impact, for papers by Mingyue Cai Breakdown of academic impact, for papers by Aaron H. Colby Breakdown of academic impact, for papers by Yawen Guo Breakdown of academic impact, for papers by Liteng Lin
Rankless by CCL
2026